$48.73
0.62% day before yesterday
Nasdaq, Dec 27, 10:00 pm CET
ISIN
US80105N1054
Symbol
SNY
Sector
Industry

Sanofi Sponsored ADR Stock price

$48.73
+0.01 0.02% 1M
+0.65 1.35% 6M
-1.00 2.01% YTD
-1.02 2.05% 1Y
-1.77 3.51% 3Y
-2.13 4.19% 5Y
+2.39 5.16% 10Y
Nasdaq, Closing price Fri, Dec 27 2024
+0.30 0.62%
ISIN
US80105N1054
Symbol
SNY
Sector
Industry

Key metrics

Market capitalization $121.61b
Enterprise Value $140.11b
P/E (TTM) P/E ratio 26.73
EV/FCF (TTM) EV/FCF 23.79
EV/Sales (TTM) EV/Sales 2.94
P/S ratio (TTM) P/S ratio 2.55
P/B ratio (TTM) P/B ratio 1.57
Dividend yield 4.18%
Last dividend (FY24) $2.04
Revenue growth (TTM) Revenue growth 5.18%
Revenue (TTM) Revenue $47.68b
EBIT (operating result TTM) EBIT $10.14b
Free Cash Flow (TTM) Free Cash Flow $5.89b
EPS (TTM) EPS $1.82
P/E forward 15.23
P/S forward 2.52
EV/Sales forward 2.90
Short interest 0.20%
Show more

Is Sanofi Sponsored ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

Sanofi Sponsored ADR Stock Analysis

Unlock Scores for Free

Analyst Opinions

22 Analysts have issued a Sanofi Sponsored ADR forecast:

17x Buy
77%
3x Hold
14%
2x Sell
9%

Analyst Opinions

22 Analysts have issued a Sanofi Sponsored ADR forecast:

Buy
77%
Hold
14%
Sell
9%

Financial data from Sanofi Sponsored ADR

Income Statement P&L | Balance Sheet | Cash Flow


TTM Annually
Jun '24
+/-
%
47,675 47,675
5% 5%
100%
- Direct Costs 18,371 18,371
9% 9%
39%
29,304 29,304
3% 3%
61%
- Selling and Administrative Expenses 6,830 6,830
10% 10%
14%
- Research and Development Expense 7,523 7,523
7% 7%
16%
14,951 14,951
8% 8%
31%
- Depreciation and Amortization 4,815 4,815
32% 32%
10%
EBIT (Operating Income) EBIT 10,136 10,136
1% 1%
21%
Net Profit 4,558 4,558
49% 49%
10%

In millions USD.

Don't miss a Thing! We will send you all news about Sanofi Sponsored ADR directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Sanofi Sponsored ADR Stock News

Neutral
GlobeNewsWire
6 days ago
Sanofi initiates phase 3 program for PCV21 and expands collaboration with SK bioscience for next-generation pneumococcal conjugate vaccines
Neutral
GlobeNewsWire
10 days ago
Jean-Paul Kress to join Sanofi's Board of Directors Paris, December 19, 2024. Sanofi's Board of Directors is pleased to welcome Jean-Paul Kress as an independent director as of January 1, 2025, replacing Gilles Schnepp who has decided to leave the Board at the end of 2024.
Positive
Investopedia
11 days ago
U.S.-traded shares of Teva Pharmaceuticals (TEVA) and Sanofi (SNY) took off Tuesday after the two drugmakers reported positive results from a study of their treatment for ulcerative colitis (UC) and Crohn's disease.
More Sanofi Sponsored ADR News

Company Profile

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.

Head office France
CEO Paul Hudson
Employees 87,994
Founded 1994
Website www.sanofi.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today